Robert Merrill Hunter Insider Profile
4 Followers
Robert Merrill Hunter, Ten Percent Owner at Cardiff Oncology, holds 7.24M shares in Synergy Pharmaceuticals Inc (Ticker: SGYPQ), holds 5.07M shares in Cardiff Oncology (Ticker: CRDF).
Robert Merrill Hunter's Trading History
| SGYPQSynergy Pharmaceuticals Inc | Jan 22, 2013 | ― | Uninformative Buy | ― | $43.46K | |
| CRDFCardiff Oncology | Apr 16, 2012 | Ten Percent Owner | Informative Buy | 200.00K | $3.68M |
You May Also Like
Robert Merrill Hunter insider profile FAQ
What is the percentage of profitable transactions made by Robert Merrill Hunter?
The percentage of profitable transactions made by Robert Merrill Hunter is 100%.
What is the average return per transaction made by Robert Merrill Hunter?
The average return per transaction made by Robert Merrill Hunter is 89.90%.
What stocks does Robert Merrill Hunter hold?
Robert Merrill Hunter holds: CRDF, SGYPQ stocks.
What was Robert Merrill Hunter's most profitable transaction?
Robert Merrill Hunter’s most profitable transaction was an Informative Buy of CRDF stock on January 23, 2012. The return on the trade was 142.70%.
What is Robert Merrill Hunter's role in Cardiff Oncology?
Robert Merrill Hunter's role in Cardiff Oncology is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
